Riskpilot← Back to searchSign inGet full accessGalaXzio Pharma lab AB
ABActiveOrg 5592143209Bunsta 103Research and experimental development on natural sciences and engineering · NACE 7210Est. 20190 employees
Revenue 2025
SEK 0
EBITDA margin
—
+5% vs 2024
Equity ratio
-10.9%
Financial strength
Net profit 2025
SEK -26K
+6% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -26K | +5% |
| Net profit | SEK -26K | +6% |
| Total assets | SEK 36K | -46% |
| Equity | SEK -4K | -118% |
| Employees | 0 | — |
Legal name
GalaXzio Pharma lab AB
Org number
5592143209
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8 augusti 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Firman tecknas ensam av externa firmatecknaren
Company purpose
Företaget ska bedriva verksamhet inom läkemedelsområdet. Utveckling av läkemedelsberedningsformer, substanskombinationer, generiska läkemedel. Företaget ska bedriva konsultverksamhet inom läkemedelsindustrin såsom uppdrag från läkemedelsbolag kring läkemedelsrekommendationer, förmånsansökningar och marknadsföring. Handel med värdepapper samt med ovan beskrivning förenlig verksamhet.
Address
Bunsta 103
Email
gidevall@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 180 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | — | — | −28 | −26 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 0 | 0 | 0 | −28 | −26 |
| Net financials | — | — | — | — | 0 |
| Profit before tax | 0 | 0 | 0 | −28 | −26 |
| Tax | −0 | — | — | — | — |
| Net profit | 0 | — | — | −28 | −26 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 50 | 50 | 50 | 67 | 36 |
| Equity | 50 | 50 | 50 | 22 | −4 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | — | — | 44 | 40 |
| Total debt | — | — | — | 44 | 40 |
EBITDA margin
-2634900.0%
This company
15.8%
Market median
-16676682% vs market
20212025
Equity ratio
-10.9%
This company
38.2%
Market median
-129% vs market
20212025
Return on equity
-2612700.0%
This company
18.4%
Market median
-14199557% vs market
20212025
Net profit margin
-2612700.0%
This company
8.1%
Market median
-32255656% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
10.15×
This company
0.62×
Market median
-1537% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA External Signatory | External Signatory | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Deputy Board Member | 2024 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GalaXzio Pharma lab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Alexius Tiger Karlsson | External Signatory | 0 companies |
| Christina Louise Margareta Bornäs | Deputy Board Member | 0 companies |
| Andreas Söderman | Board of Directors | 0 companies |
| Anna Charlotta Söderlind | Deputy Board Member | 0 companies |
| Anders Daniel Gidevall | Chairman | 0 companies |